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Spirobicyclic diamines 2: Synthesis of homochiral diastereoisomeric proline derived [4,4]-
spirolactams. 
 
Fintan Kelleher* and Sinead Kelly 
 
Reductive amination of homochiral primary amines ((R)- or (S)--methyl benzylamine, and (R)- or (S)-alanine methyl 
ester) with a racemic proline derived aldehyde, followed by cyclisation gave diastereoisomeric [4.4]-spirolactams.  
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Abstract: 
L-Proline derived diastereoisomeric [4.4]-spirolactams have been prepared by a 
reductive-amination reaction of (R)- or (S)-alanine methyl ester followed by thermal 
cyclisation of the resulting amine onto the proline ester group in refluxing toluene. 
Under similar conditions (R)- or (S)-phenylalanine methyl ester gave no cyclisation 
products, while R- or S--methylbenzylamine required treatment with NaNH2 in 
refluxing toluene to induce cyclisation giving diastereoisomeric [4.4]-spirolactams. 
 
There are currently a large number of methods for the synthesis of spirocyclic 
compounds and they can also be easily formed in a stereocontrolled manner.
1
 
Although Freidinger was the first to incorporate a lactam constraint into the backbone 
of a peptide in order to rigidify the peptide tertiary structure into a more defined 
conformation,
2
 this is now a widely used method to constrain the secondary structures 
of peptides. Of the range of methods available for lactam synthesis one of the most 
common is the cyclisation of an amino group (primary or secondary) onto a 
carboxylic ester, with concomitant loss of an alcohol. Many of the reactions take 
place spontaneously at ambient temperature, while others require heating in a suitable 
solvent.
2b,3
 The overall efficiency of the cyclisation is dependent on a number of 
factors including the size of the ring being formed, the nature of the amino 
substitutent in the case of a secondary amine, any substituents on the resulting ring 
and the structure of the alkyl moiety of the ester group. 
 
                                                 
†
  see reference 4. 
L-Proline derived spirolactams have, in particular, been studied for their use in 
constraining peptides with L-proline residues to mimic a -turn, a very important 
component of peptide secondary structures.
3
 As part of a program to synthesise both 
homochiral and racemic proline derived [4.4]-spirolactams, we recently reported on 
our studies on the preparation of racemic spirolactams by a thermal intramolecular 
ester aminolysis method.
4
 The route we employed is shown in Figure 1, where N-Boc 
L-proline methyl ester was -alkylated with allyl bromide, using LiHMDS as base. 
The alkene of the allyl group was oxidatively cleaved by the OsO4/NaIO4 system to 
give the aldehyde 4. Reductive amination of the aldehyde with allyl amine, 
benzylamine or glycine methyl ester gave the desired secondary amines 5 as suitable 
cyclisation precursors. Heating solutions of the amino esters 5 in refluxing toluene 
gave [4.4]-spirolactams 6 in yields of 66-90%. Since the amines used in this study 
were achiral, the resulting spirolactams were obtained as racemic mixtures. It was of 
interest to us to examine the extension of the scope of the reaction by employing 
chiral amines, for example R- or S--methylbenzylamine. This would result in 
diastereoisomeric amino esters which would, in each case, give a mixture of two 
spirolactams after cyclisation. It was expected that these diastereoisomeric 
compounds would be separable by column chromatography, giving us a route to all 
four homochiral [4.4]-spirolactams from a common racemic precursor, namely 
aldehyde 4. 
 
Reductive amination of 4 with either R- or S--methylbenzylamine cleanly gave 5a 
and 5b, the desired precursors to the spirolactams. Using the conditions employed in 
our previous studies, i.e. stirring in toluene at reflux, did not give any of the desired 
[4.4]-spirolactam cyclisation products, with only starting material being isolated in 
each case, even after prolonged heating. It was therefore apparent that the extra steric 
hindrance in the system with the addition of an extra methyl group in the position  to 
the nitrogen of the amine compared to benzylamine, was sufficient to stop cyclisation 
from occurring. We surmised that converting the secondary amine cyclisation 
precursor to a secondary lithium or sodium amide ion, by deprotonation with a 
sufficiently strong base would give a stronger nucleophile which might be able to 
overcome the inherent steric hindrance of the system. Since we had done all our 
cyclisations in refluxing toluene and sodium amide is commercially available as a 
50% solution in toluene, this was the strong base that we employed. Treating 
solutions of the secondary amines 5a or 5b, dissolved in toluene, with NaNH2 in 
toluene, gave no indication of cyclisation after stirring at ambient temperature, but 
when the solutions were stirred at reflux, cyclisation proceeded with the desired 
spirolactams 6a-d (as pairs of diastereoisomers which were separable by column 
chromatography) being isolated in yields of 30% and 51% from aldehyde 4 (Scheme 
1). In both cases the ratio of diastereoisomers isolated was approximately 1:1. 
 
Although the stereochemistry of the -methyl benzyl substituent was known from our 
choice of the starting homochiral amine we were unaware of the absolute 
stereochemistry of the spiro centre in each of the four isolated diastereoisomers. We 
were unable to obtain crystals of sufficient quality for X-ray analysis of the structure. 
Moleculer modelling
5
 was used to give minimised energy conformations of the RR 
and SR diastereisomeric pair 6a and 6b. It was immediately evident from the 
minimised structures (Figure 2) that in the SR diastereoisomer the hydrogens of the 
Boc protecting group  and the meta hydrogens of the phenyl group were close in 
space (closest distance of 2.67 Å), whereas in RR isomer the Boc and phenyl groups 
were a large distance apart. As a result of this it was expected that NOE NMR 
experiments would be able to distinguish between the two diastereoisomers. We were 
pleased to find that irradiation of the signal for the hydrogens of the Boc group of the 
diastereoisomer assigned as SR did indeed show an NOE to the phenyl hydrogens, 
whilst no similar NOE was observed in the case of the RR diastereoisomer. Although 
this is not conclusive proof of the absolute stereochemistry of the spiro centre we have 
now tentatively assigned the stereochemistry, based on the molecular modelling and 
NOE studies, of all four diastereoisomers. 
 
We next examined the synthesis of diastereoisomeric spirolactams with carboxylic 
ester side-chains on the lactam nitrogen. Previously we had found that when glycine 
methyl ester was used cyclisation was very efficient. The use of (R)-alanine methyl 
ester, with the incorporation of a methyl group in the position  to the nitrogen was 
expected to reduce considerably, or possibly completely stop, cyclisation from taking 
place under the thermal ester aminolysis protocol. We found that using the thermal 
cyclisation method the two diastereoisomeric spirolactams 6e and 6f were obtained in 
a much reduced yield of 40% even after stirring for 3 days in refluxing toluene, 
compared to the 90% for glycine methyl ester after stirring for 24 h in refluxing 
toluene (Scheme 2). The diastereoisomeric ratio in this case was 6:1. Repeating the 
synthesis, but this time using (S)-alanine methyl ester again for 3 days in refluxing 
toluene, gave the two diastereoisomeric spirolactams 6g and 6h in an a slightly 
improved yield of 54%. The diastereoisomeric ratio in this case was 1.75:1. As 
before, we were unable to obtain crystals of sufficient quality for X-ray analysis from 
any of the four diastereoisomeric compounds. For both sets of reactions the remaining 
material was the unreacted amino cyclisation precursors 5c and 5d.  
 
We expected that increasing the steric bulk of the amino acid component would cause 
a further reduction in the isolated yield of the diastereoisomeric spirolactams. When 
(S)-phenylalanine methyl ester was used no spirolactam products were isolated with 
the secondary amine 5f being isolated as an inseparable mixture of diastereoisomers 
(one spot by TLC) in a 72% yield, while use of (R)-phenylalanine methyl ester gave a 
similar result with the uncyclised diastereoisomeric amines 5e being obtained in a 
yield of 80% (Scheme 3). 
 
In conclusion, it is apparent that the size of the -substituents on the primary amine 
component is critical to the overall success of the thermal ester aminolysis method for 
the synthesis of proline derived [4.4]-spirolactams, with a group larger than methyl 
causing the complete absence of any products arising from cyclisation. It would be 
our recommendation that for the synthesis of homochiral proline derived [4.4]-
spirolactams with larger groups on the lactam nitrogen, the thermal ester aminolysis is 
not the method of choice. It is more appropriate to synthesise the cyclisation 
precursor, hydrolyse the proline ester, and then to use peptide coupling methods to 
induce lactamisation.
3
 Currently, we are attempting to obtain crystals suitable for X-
ray analysis of a number of derivatives of these spirolactams and we are also 
examining their chemical properties. The results of these studies will be reported in 
due course. 
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Figure 1. Synthesis of racemic [4.4]-spirolactams.
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Scheme 1: Reagents and conditions; (a) i) (R)--methylbenzylamine, MgSO4, MeOH, ii) NaBH4, rt; (b) NaNH2 in 
toluene, reflux, 30% from 4; (c) i) (S)--methylbenzylamine, MgSO4, MeOH, ii) NaBH4, rt; (d) NaNH2 in toluene, 
reflux, 51% from 4;
b
N
N
Boc O
+
N CO2Me
Boc
H
N N
N
Boc O
N
N
Boc O
+
5a
6b
6c
6d
 
 
 
N CO2Me
Boc
O
N CO2Me
Boc
H
N N
N
Boc O
a
c
d
4
6e
5d
Scheme 2: Reagents and conditions; (a) i) (R)-alanine, MgSO4, MeOH, ii) NaBH4, rt; (b) toluene, reflux, 40% 
from 4; (c) i) (S)-alanine, MgSO4, MeOH, ii) NaBH4, rt; (d) toluene, reflux, 54% from 4;
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Scheme 3: Reagents and conditions; (a) i) (R)-phenylalanine, MgSO4, MeOH, ii) NaBH4, rt, 80%; 
(b) i) (S)-phenylalanine, MgSO4, MeOH, ii) NaBH4, rt, 72%.
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Figure 2. Energy minimised conformations of 6b (S,R) and 6a (R,R).
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